Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Datametrex AI Ltd V.DM

Alternate Symbol(s):  DTMXF

Datametrex AI Limited is a technology-focused company with exposure to artificial intelligence, healthcare, and mobile gaming. It is focused on collecting, analyzing and presenting structured and unstructured data using machine learning and artificial intelligence. The Company's products include AnalyticsGPT, Cyber Security, and Healthcare. AnalyticsGPT platform scans vast data streams from social media, news, blogs, forums, messengers, enterprise data, and the dark Web, creating predictive analytics. Cyber Security is a deep analytics platform that captures, structures, and visualizes vast amounts of unstructured social media data, which is used as a discovery tool that allows organizations to make decisions. It offers Nexa Products, which consists of NexaSecurity and NexaSMART. Healthcare consists of Imagine Health Centres, a multidisciplinary healthcare facility, and Medi-Call, a telehealth platform. The Company also offers a mobile blockchain game, Cereal Crunch.


TSXV:DM - Post by User

Comment by MLorenzoon Feb 15, 2021 7:25pm
205 Views
Post# 32570003

RE:25,000 tests/week in Q2

RE:25,000 tests/week in Q2I agree that the weekly testing numbers should continue to increase and remain fairly constant. 50,000/wk in Q3 is very aggressive as testing is incremental not exponential, but the company should see the testing and capacity numbers increase for the forseable future.
These numbers are also just based on Canadian sales, Gunter has spoken about major EU, Middle Eastern and African contracts which could substantially raise the weeklt numbers.
I also belive that testing will be around for at least 2-4 more years, so this constant cash will be very beneficial to the AI business which will probably need substantial investment for that same time time period.
ML
<< Previous
Bullboard Posts
Next >>